BARCLAYS PLC - PASSAGE BIO INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q3 2023$9
-25.0%
13,1530.0%0.00%
Q2 2023$12
-7.7%
13,1530.0%0.00%
Q1 2023$13
-27.8%
13,1530.0%0.00%
Q4 2022$18
-99.9%
13,1530.0%0.00%
Q3 2022$16,000
-50.0%
13,153
-3.0%
0.00%
Q2 2022$32,000
-48.4%
13,559
-32.0%
0.00%
Q1 2022$62,00019,9310.00%
Other shareholders
PASSAGE BIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,959,769$15,375,00015.35%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,235,869$3,831,0004.65%
New Leaf Venture Partners, L.L.C. 2,497,922$7,744,0003.82%
Frazier Life Sciences Management, L.P. 5,009,219$15,529,0001.32%
Deep Track Capital, LP 3,375,000$10,463,0000.67%
Orbimed Advisors 7,331,999$22,729,0000.37%
Lynx1 Capital Management LP 105,504$327,0000.30%
XTX Topco Ltd 94,309$292,0000.13%
Woodline Partners LP 1,913,880$5,933,0000.10%
GREAT POINT PARTNERS LLC 113,900$353,0000.08%
View complete list of PASSAGE BIO INC shareholders